Connect with us

Press Releases

Immunovia Announces CEO Transition: Appoints Patrik Dahlen as New CEO

LUND, Sweden , Aug. 26, 2020 /PRNewswire/ — Immunovia AB (publ) (“Immunovia”), today announced that the Board of Directors has appointed Patrik Dahlen as new CEO starting November 1, 2020. Patrik Dahlen has extensive experience as previous CEO of several diagnostic companies and succeeds…

Avatar

Published

on

LUND, Sweden , Aug. 26, 2020 /PRNewswire/ — Immunovia AB (publ) (“Immunovia”), today announced that the Board of Directors has appointed Patrik Dahlen as new CEO starting November 1, 2020. Patrik Dahlen has extensive experience as previous CEO of several diagnostic companies and succeeds Mats Grahn who has successfully brought the company from development to commercial stage over the last seven years. Mats has now been nominated as a member of the Company’s board.

Patrik Dahlen is a seasoned executive with broad international experience and brings substantial diagnostic and international industry expertise. As Chief Executive Officer of Dako, Patrik, carried out a major strategic repositioning of the company as a leading supplier of cancer diagnostics, which resulted in the acquisition by Agilent for $2.2 billion. As President of Life Sciences at the American company Perkin Elmer, Patrik was instrumental in building the company’s diagnostic business with a niche focus on diagnostic systems for neonatal and prenatal screening. He has led organizations ranging from 10 to 2000 people based in Finland, Denmark, UK and USA and has considerable public company experience.

CEO, Mats Grahn, and the Chairman of the Board, Carl Borrebaeck, will host a webcast to discuss further and hold a question and answer session today. The live webcast is scheduled to begin at 4:00 p.m. CET on August 26, 2020.

Event Details:

To join the webinar: Register for Webinar

“Immunovia is one of a few companies that has the possibility to fundamentally change cancer diagnostics in order to meet significant unmet clinical needs with its cutting-edge platform technology IMMray™. I couldn’t be more honored to have been chosen to lead the company’s next growth phase. The opportunities for Immunovia are vast, and to seize it we must continue to have a clear focus, move our commercial initiatives with excellence and continue to transform as we grow,” says Patrik Dahlen.

“We are thrilled to welcome Patrik Dahlen as our new CEO during this pivotal time at the company, as we aim for a successful sales start of our first product, which is a true milestone on our path towards the company’s vision to become a leader in early detection of complex diseases such as cancer. Patrik has a truly solid commercial background in the diagnostic sector and will add valuable expertise through his proven track record of driving and expanding sales into international markets. The Board strongly believes that Patrik has the necessary skills, vision and determination to build on the foundations that current CEO Mats Grahn has successfully laid in recent years,” says Carl Borrebaeck, Chairman of Immunovia.

“I am pleased to hand over Immunovia to Patrik, whom I know as one of the most experienced and strongest leaders in the international diagnostics industry.  Patrik is the perfect choice for Immunovia at a time when the Company is transforming from a development to a commercial expansion stage enterprise. I have enjoyed every minute of the journey in building Immunovia from world leading academic research to where it is today, an established and successful company,” says Mats Grahn.

“Mats has done a fantastic job in building Immunovia, including the creation of the largest network of clinical experts and a full-scale US commercial unit. With his drive and vision, he has demonstrated the potential of advanced clinical cancer tests thereby building shareholder value. In order to secure continued access to Mats broad expertise and experience, the nomination committee has decided to nominate Mats Grahn as a board member of Immunovia at an Extra General Meeting,” Carl Borrebaeck continues.

Information about an Extra General Meeting will be published separately during Q3 2020.

This is information that Immunovia is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 8:30 CET on August 26, 2020.

For more information, please contact:

Julie Silber, Director of Investor Relations, Immunovia
Email: [email protected]
Tel: +46 7 93 486 277

About Immunovia

Immunovia AB is a diagnostic company that is developing and commercializing highly accurate blood tests for the early detection of cancer and autoimmune diseases based on Immunovia’s proprietary test platform called IMMray™. Tests are based on antibody biomarker microarray analysis using advanced machine-learning and bioinformatics to single-out a set of relevant biomarkers that indicate a certain disease. Thus, forming a unique “disease biomarker signature”.

The company was founded in 2007, based on cancer studies and ground-breaking research in the Department of Immuntechnology at Lund University and CREATE Health Cancer Center, Sweden.

The first product, IMMray™ PanCan-d, is undergoing clinical evaluation in some of the world’s largest clinical studies for pancreatic cancer, PanFAM-1, PanSYM-1 and PanDIA-1 and is currently in the final validation for sales start Q4 2020. When validated, IMMray™ PanCan-d will be the first blood-based test for early diagnosis of pancreatic cancer on the market, with a potential to significantly improve patient survival and outcome.

Immunovia Dx Laboratories located in Marlborough, Massachusetts, USA and Lund, Sweden will provide laboratory testing services in two accredited reference laboratories.

Immunovia’s shares (IMMNOV) are listed on Nasdaq Stockholm. For more information, please visit www.immunovia.com.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/immunovia-ab/r/immunovia-announces-ceo-transition–appoints-patrik-dahlen-as-new-ceo,c3181074

The following files are available for download:

SOURCE Immunovia AB

Source: https://www.prnewswire.com:443/news-releases/immunovia-announces-ceo-transition-appoints-patrik-dahlen-as-new-ceo-301118600.html

Continue Reading

Press Releases

The Film Detective Announces World Premiere of Salem and The Scarlet Letter (2020)

Forty years in the making, The Film Detective is proud to premiere a historic tribute to the city of Salem from legendary independent filmmaker Samuel M. Sherman.

Avatar

Published

on

Forty years in the making, The Film Detective is proud to premiere a historic tribute to the city of Salem from legendary independent filmmaker Samuel M. Sherman.

Press Release updated: Nov 23, 2020 11:00 EST


​​​The Film Detective (TFD), a classic media streaming network and film archive that restores and distributes classic films for today’s cord-cutters announces the worldwide premiere of Salem and The Scarlet Letter (2020) – coming to The Film Detective on Nov. 25, 2020, at 6:30 PM ET.

Independent filmmaker and producer Samuel M. Sherman spearheaded Salem and The Scarlet Letter, both writing and directing this compelling tribute to the historic city of Salem, Massachusetts, and one of its best-remembered residents – Nathaniel Hawthorne.

Originally filmed in 1978, Salem and The Scarlet Letter blends stunning location footage of Salem, including Nathaniel Hawthorne’s birthplace, The House of the Seven Gables, and more. The film explores Salem’s broad history, from the Salem Witch Trials to the inspiration Nathaniel Hawthorne drew from the city to create his famous work, The Scarlet Letter.

The documentary receives the Hollywood treatment with narration from actor John Carradine, prolific player for some of Hollywood’s finest directors, including Cecil B. DeMille and John Ford in works like Stagecoach (1939) and The Ten Commandments (1956). Salem and The Scarlet Letter served as one of many collaborations between Sherman and Carradine, also having worked on Blood of Dracula’s Castle (1969) and Blood of Ghastly Horror (1967), directed by Sherman’s late filmmaking partner and co-founder of Independent-International Pictures, Al Adamson.

At the core of Salem and The Scarlet Letter is a deep appreciation for Salem’s rich history, perfectly expressed by the film’s subject, Nathaniel Hawthorne, who wrote “This old town of Salem–my native place…possesses, or did possess, a hold on my affections, the force of which I have never realized during my seasons of actual residence here.”

From a single viewing of Salem and The Scarlet Letter, film and history fans alike will have little question as to how Hawthorne found such a fondness for Salem. 

Said director Samuel M. Sherman, “Salem and The Scarlet Letter is a classic project of mine concerning one of my favorite films, the 1934 version of The Scarlet Letter. My first visit to Salem in 1965 so impressed me that I made up my mind to do a documentary about the town and famous author Nathaniel Hawthorne at some time in the future. Phil Hopkins and The Film Detective have made completing this longtime project of mine a reality. I am pleased with the final version and I hope that modern audiences will appreciate it as a viewing prologue to the 1934 The Scarlet Letter for which purpose I originally intended it.”

The Film Detective is proud to bring audiences this cinematic tour of Salem from the comfort of home. Salem and The Scarlet Letter will premiere on Wednesday, Nov. 25 at 6:30 PM ET followed by the 1934 adaptation of The Scarlet Letter.

Subscribers to The Film Detective app can also watch Salem and The Scarlet Letter anytime. For more information, visit www.thefilmdetective.com.

Contact:

Kerry Ryan

kerry@thefilmdetective.com

About The Film Detective:

The Film Detective is a leading streaming network of restored classic programming, distributing its extensive library of 3,000+ hours of film on DVD and Blu-ray and through leading platforms including TCM, NBC, EPIX, Amazon, MeTV, PBS, and more. TFD has released its classic movie app on web, Android, iOS, Roku, Amazon Fire TV, and Apple TV and is available live on Sling, STIRR, Plex, and DistroTV.

Source: The Film Detective

Source: https://www.newswire.com/news/the-film-detective-announces-world-premiere-of-salem-and-the-scarlet-21261970

Continue Reading

Press Releases

ThoughtWorks Honored 2020 Asia-Pacific WEPs Awards by UN Women

BEIJING, Nov. 23, 2020 /PRNewswire/ — November 18th, 2020, ThoughtWorks was invited to join 2020 International Conference on Gender Equality and Corporate Social Responsibility (CSR) & Women’s Empowerment Principles (WEPs) awards ceremony, which was held by UN Women China in partnership…

Avatar

Published

on

Over the years, ThoughtWorks has committed to develop a business and culture environment that promote gender-inclusive and gender equality. The company encourages women in technology to play a greater influence at workplace, marketplace and social community.

Yao Yao, a member of ThoughtWorks China management team, has been actively engaged in development of women in technology. Speaking at the ceremony, Ms. Yao said, “It is a great recognition for ThoughtWorks to be awarded 2020 Asia-Pacific WEPs Awards by UN Women”.

Attended by nearly 150 private sector leaders, social entrepreneurs, civil society representatives along with EU and UN officials, the conference took time to reflect the progress made on gender equality and women empowerment in later stage of the pandemic new norm, challenges and future expectations were also talked at the conference.

In the conference, it emphasized the importance of integrating gender equality into enterprise strategy and enterprise social responsibility projects. Guests shared their experience, best practice and challenges. Enterprise social responsibility projects play a key role at workplace and social equality. Creative practices on female leadership, decent work and digital inclusion were also shared.

At the opening, Smriti Aryal, Head of UN Women China office called on all participants to actively embrace international standards on enterprise commitment, strategy and project proposal; and all the stakeholders should make their voices heard. She mentioned, “The private sector, companies and enterprises have a key role to play. An employer can bring a positive impact by creating decent work opportunities, promoting equal pay for equal work, and reducing the burden of unpaid care work for women. Meanwhile, it is also important for companies to promote the next generation of female leaders as the decision-maker for future business practices”.

Ms. Mu Hong, Director-General of Liaison Department at All China Women’s Federation, presented the work ACWF has done in advancement of gender equality in China, and stressed the importance of adding gender factor to local policy and practice. She said, “Guaranteeing equal economy right and strengthening economic empowerment for women is an important topic, which will be a key part for next round of the Program of China’s Women Development”.

Mr. Nicolas Chapuis, Head of Delegation, European Union Delegation to China, reminded the audience about the European Union’s longstanding commitment towards gender equality. As global leader, the gender equality strategy of EU will continue to make its contribution to a gender equal world. Mr. Chapuis said, “The gender equality strategy is aimed at promote worldwide gender equality and enhance women empowerment. EU will continue to raise gender equality issue in global partnership and political dialogue with the third country. We push for gender equality in EU and beyond.”

Ms. Zhang Haidi, president of the China Federation of the Disabled stressed: “The disabled female is the most disadvantaged group in human society that need help badly, and they are also an important force in promoting peace and development. The sustainable development of humankind needs to rely on and bring benefit to the disabled female.”

In the conference, UN Women presented WEPs Award to 10 prize-winners. As the first WEPs Initiative in Asia-Pacific, the award is intended to applaud model business practices that in compliance with gender equality of Women’s Empowerment Principles proposed by UN Women and United Nations Global Compact. WEPs has 7 principals, encouraging enterprises put gender awareness in the whole value chain of its business.

Yao Yao of ThoughtWorks spoke on behalf of enterprise leadership receiving the award, “For many years, we have been trying our best to influence the society, push for gender-inclusive and gender equality in business world, and women in technology is always the focus. ThoughtWorks finished IT experts title open reply just recently, and female account for 45% of the newly promoted experts! With the helping hands of more fellows, we wish to fulfill our commitment with tangible action by offering bigger platform for these excellent female in technology, so that they can lead by example for females in other industries.”

WEPs is the main tool for enterprises to reach gender equality target of the 2030 Agenda for Sustainable Development. To date, 102 companies in China have pledged action to advance the WEPs, and more than 3,700 companies have done so globally. An international network of like-minded companies, the WEPs platform connects businesses of all sizes across multiple industries, including corporations such as ThoughtWorks, Alcatel-Lucent, IKEA, Microsoft and Unilever, among many others as signatories. The year of 2020 is 10th anniversary since the launch of WEPs.

About the Organizer:

About UN Women

UN Women is the UN organization dedicated to gender equality and the empowerment of women. A global champion for women and girls, UN Women was established to accelerate progress on meeting their needs worldwide. Working in China since 1998, UN Women provides technical and financial assistance to innovative programmes and strategies for gender equality and women’s empowerment.

About the Delegation of the European Union to China

The European Union is represented in China by the Delegation in Beijing. The Delegation was established in Beijing in October 1988.

The Delegation has full diplomatic privileges and immunities with the Head of Delegation accorded full ambassadorial status. The Delegation is responsible for the conduct of official relations between China and the European Union. In all matters pertaining to the European Union, the Delegation works closely with the diplomatic missions of the EU Member States. The Delegation is the vital link between European Union and Chinese government as well as its Diplomatic Corps.

About ThoughtWorks

Established in 1993, ThoughtWorks is a global software consulting company with excellent delivery record. Targeting at clients which are leading players in the world, our services include organization transition advisories, innovative software delivery, UE design and product solutions. ThoughtWorks has a global client base with leading companies in industries like automobile, finance and insurance, healthcare, tourism, transport, retails, e-commerce, energy and public utilities.

Around the world ThoughtWorks has 43 offices in 14 countries with more than 7,000 employees on board. It entered China in 2004 and today has more than 2,000 employees based respectively in 7 cities in Beijing, Hong Kong, Xi’an, Chengdu, Shanghai, Wuhan and Shenzhen.

SOURCE ThoughtWorks

Related Links

https://www.thoughtworks.com/?utm_campaign=technology&utm_medium=pr&utm_source=pr

Source: https://www.prnewswire.com:443/news-releases/thoughtworks-honored-2020-asia-pacific-weps-awards-by-un-women-301178986.html

Continue Reading

Press Releases

ARUP Laboratories Announces the Availability of a Combined Test for COVID-19, Influenza, and RSV

SALT LAKE CITY, Nov. 23, 2020 /PRNewswire/ — ARUP Laboratories today announced the availability to clients nationwide of a combined test to detect and differentiate COVID-19, influenza, and/or respiratory syncytial virus (RSV) in individuals with respiratory symptoms consistent with…

Avatar

Published

on

SALT LAKE CITY, Nov. 23, 2020 /PRNewswire/ — ARUP Laboratories today announced the availability to clients nationwide of a combined test to detect and differentiate COVID-19, influenza, and/or respiratory syncytial virus (RSV) in individuals with respiratory symptoms consistent with COVID-19. The test is the first offered in the United States to be developed using Thermo Fisher Scientific’s TaqMan SARS-CoV-2, Flu A/B, RSV multiplex primer and probes and run on the QuantStudio Real-Time Polymerase Chain Reaction (PCR) platform.

“We are proud to offer this test, which is one of the first available to test for all four viruses,” said Adam Barker, PhD, director of ARUP’s COVID-19 Rapid Response Laboratory. “This single test is a simple, accurate way to determine which virus is the cause of illness as the flu and RSV seasons get underway amid the COVID-19 pandemic.”

ARUP’s Influenza, SARS-CoV-2, and RSV by NAA test detects ribonucleic acid (RNA) from SARS-CoV-2, the virus that causes COVID-19, along with the influenza A and B viruses and RSV. A qualitative test, it also differentiates between the viruses, although it does not differentiate between influenza A and B.

The test can be performed on specimens collected using a deep nasal swab, or on specimens collected from the back of the throat and the front of both nostrils.

It adds to ARUP’s menu of COVID-19-related tests, which includes a molecular diagnostic test for COVID-19 that can be performed on multiple specimen types including saliva.

ARUP also offers two IgG antibody tests to detect previous exposure to SARS-CoV-2, along with numerous tests that help guide treatment of patients with the virus.

“The challenge clinicians face as we enter flu season is unparalleled even if flu and RSV activity remain low,” said ARUP CEO Sherrie L. Perkins, MD, PhD. “We’re pleased that this combination test will help them provide the best patient care possible as the pandemic persists.”

About ARUP Laboratories
Founded in 1984, ARUP Laboratories is a leading national reference laboratory and a nonprofit enterprise of the University of Utah and its Department of Pathology. ARUP offers more than 3,000 tests and test combinations, ranging from routine screening tests to esoteric molecular and genetic assays. ARUP serves clients across the United States, including many of the nation’s top university teaching hospitals and children’s hospitals, as well as multihospital groups, major commercial laboratories, group purchasing organizations, military and other government facilities, and major clinics. In addition, ARUP is a worldwide leader in innovative laboratory research and development, led by the efforts of the ARUP Institute for Clinical and Experimental Pathology®. ARUP is ISO 15189 CAP accredited.

Media Contact
ARUP: Lisa Carricaburu, [email protected], 801-541-5041

SOURCE ARUP Laboratories

Related Links

aruplab.com

Source: https://www.prnewswire.com:443/news-releases/arup-laboratories-announces-the-availability-of-a-combined-test-for-covid-19-influenza-and-rsv-301178985.html

Continue Reading
Blockchain46 mins ago

Blockchain46 mins ago

Blockchain46 mins ago

Blockchain46 mins ago

Blockchain46 mins ago

Blockchain46 mins ago

Blockchain46 mins ago

Blockchain46 mins ago

Blockchain46 mins ago

Blockchain46 mins ago

Saas51 mins ago

Saas51 mins ago

Saas51 mins ago

Saas51 mins ago

Saas51 mins ago

Saas51 mins ago

Saas51 mins ago

Saas51 mins ago

Saas51 mins ago

Saas51 mins ago

Blockchain1 hour ago

XRP, Synthetix, Crypto.com Coin Price Analysis: 23 November

Blockchain1 hour ago

CipherTrace will Anonymität von Privacy Coins an den Kragen

Private Equity1 hour ago

FinTech: Western Union Acquires 15% Of Saudi Fintech stc pay For $200M

Press Releases1 hour ago

The Film Detective Announces World Premiere of Salem and The Scarlet Letter (2020)

Press Releases1 hour ago

ThoughtWorks Honored 2020 Asia-Pacific WEPs Awards by UN Women

Press Releases1 hour ago

Seacoast Bank Named to Fortune’s ‘100 Fastest-Growing Companies’ List for Third Consecutive Year

Press Releases1 hour ago

ARUP Laboratories Announces the Availability of a Combined Test for COVID-19, Influenza, and RSV

Press Releases1 hour ago

Anunciados los ganadores de los 2020 “IMTA Mountain Tourism Awards”

Press Releases1 hour ago

New Financial Factors Regulation Blocks Participant Requested Investments

Blockchain1 hour ago

Here’s why the Pickle Finance hack was different from the rest

Blockchain1 hour ago

Csak COVID-tanúsítvánnyal kaphatnánk vissza a normális életünket

Press Releases1 hour ago

Dr. Rajamannan of Most Sacred Heart of Jesus Cardiology Holds Virtual Press Conference on Outpatient Therapies for Covid-19

Press Releases1 hour ago

Alertus Technologies Announces Upcoming Virtual Seminar to Help Organizations Navigate the New COVID-19 Landscape

Startup2 hours ago

Crypto Project Gnosis Launches Futarchy-Based Governance Organization

Private Equity2 hours ago

European insurers gear up to do deals

Blockchain2 hours ago

AAX: The institutional-grade crypto derivatives platform celebrates its anniversary

Startup2 hours ago

Skype co-founder Jaan Tallinn has invested over $130M in more than 100 tech startups; now betting big on London-based AI startup Faculty.ai 

Blockchain2 hours ago

Can Falsified Lab Tests be Cured Through Blockchain?

Press Releases2 hours ago

Panaceutics Nutrition Names Veteran Biotech Exec Adam Monroe New CEO

Private Equity2 hours ago

Weekly Wrap, November 23rd, 2020; DPI, CDC, EBRD launch pharma platform, OMAI’s latest education deal, AIIM backs MetroFibre Networx and more…

Trending